Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999556 · ClinicalTrials.gov registry record
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 6
- Enrollment target
NCT01999556: Completed study, sponsored by Wake Forest University Health Sciences.
NCT01999556 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01999556 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain high quality specimens for molecular studies for the identification and characterization of genetic mutations involved in the pathogenesis of familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic clinical data, and sent to Washington University (Division of Oncology, St. Louis, MO) for molecular analyses. Some specimens sent to Washington University may also be used for quality control analyses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-12-22 |
What the finished NCT01999556 record still lists
NCT01999556 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01999556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01999556 about?
NCT01999556 is a clinical study titled "LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia". The purpose of this study is to obtain high quality specimens for molecular studies for the identification and characterization of genetic mutations involved in the pathogenesis of familial myeloid malignancies. Specimens obtained will be de-identified, linked to basic clinical data, and sent to Was...
What is the current status of trial NCT01999556?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2013-11. Estimated completion is 2016-12-22.
Who is sponsoring clinical trial NCT01999556?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia